|
1
|
Bischoff H: The mechanism of
alpha-glucosidase inhibition in the management of diabetes. Clin
Invest Med. 18:303–311. 1995.PubMed/NCBI
|
|
2
|
Krentz AJ and Bailey CJ: Oral antidiabetic
agents: Current role in type 2 diabetes mellitus. Drugs.
65:385–411. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meneilly GS, Ryan EA, Radziuk J, Lau DC,
Yale JF, Morais J, Chiasson JL, Rabasa-Lhoret R, Maheux P, Tessier
D, et al: Effect of acarbose on insulin sensitivity in elderly
patients with diabetes. Diabetes care. 23:1162–1167. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li FF, Xu XH, Fu LY, Su XF, Wu JD, Lu CF,
Ye L and Ma JH: Influence of acarbose on plasma glucose
fluctuations in insulin-treated patients with type 2 diabetes: A
pilot study. Int J Endocrinol. 2015:9035242015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
The relationship of glycemic exposure
(HbA1c) to the risk of development and progression of retinopathy
in the diabetes control and complications trial. Diabetes.
44:968–983. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Klein R: Hyperglycemia and microvascular
and macrovascular disease in diabetes. Diabetes Care. 18:258–268.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stratton IM, Adler AI, Neil HA, Matthews
DR, Manley SE, Cull CA, Hadden D, Turner RC and Holman RR:
Association of glycaemia with macrovascular and microvascular
complications of type 2 diabetes (UKPDS 35): Prospective
observational study. BMJ. 321:405–412. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Monnier L, Mas E, Ginet C, Michel F,
Villon L, Cristol JP and Colette C: Activation of oxidative stress
by acute glucose fluctuations compared with sustained chronic
hyperglycemia in patients with type 2 diabetes. JAMA.
295:1681–1637. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu Y, Liu W, Huang R and Zhang X:
Postchallenge plasma glucose excursions, carotid intima-media
thickness and risk factors for atherosclerosis in Chinese
population with type 2 diabetes. Atherosclerosis. 210:302–306.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kato T, Inoue T and Node K: Postprandial
endothelial dysfunction in subjects with new-onset type 2 diabetes:
An acarbose and nateglinide comparative study. Cardiovasc Diabetol.
9:122010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Santilli F, Formoso G, Sbraccia P, Averna
M, Miccoli R, Di Fulvio P, Ganci A, Pulizzi N, Lattanzio S,
Ciabattoni G, et al: Postprandial hyperglycemia is a determinant of
platelet activation in early type 2 diabetes mellitus. J Thromb
Haemost. 8:828–837. 2010.PubMed/NCBI
|
|
12
|
Chiasson JL, Josse RG, Gomis R, Hanefeld
M, Karasik A and Laakso M: STOP-NIDDM Trial Research Group:
Acarbose treatment and the risk of cardiovascular disease and
hypertension in patients with impaired glucose tolerance: The
STOP-NIDDM trial. JAMA. 290:486–494. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kashiwagi A, Shinozaki K, Nishio Y,
Maegawa H, Maeno Y, Kanazawa A, Kojima H, Haneda M, Hidaka H,
Yasuda H and Kikkawa R: Endothelium-specific activation of NAD(P)H
oxidase in aortas of exogenously hyperinsulinemic rats. Am J
Physiol. 277:E976–E983. 1999.PubMed/NCBI
|
|
14
|
Monnier L, Colette C, Mas E, Michel F,
Cristol JP, Boegner C and Owens DR: Regulation of oxidative stress
by glycaemic control: Evidence for an independent inhibitory effect
of insulin therapy. Diabetologia. 53:562–571. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schnell O, Mertes G and Standl E:
Acarbose-Insulin Combination Study Group: Acarbose and metabolic
control in patients with type 2 diabetes with newly initiated
insulin therapy. Diabetes Obes Metab. 9:853–858. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weng J, Li Y, Xu W, Shi L, Zhang Q, Zhu D,
Hu Y, Zhou Z, Yan X, Tian H, et al: Effect of intensive insulin
therapy on beta-cell function and glycaemic control in patients
with newly diagnosed type 2 diabetes: A multicentre randomised
parallel-group trial. Lancet. 371:1753–1760. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Service FJ, Molnar GD, Rosevear JW,
Ackerman E, Gatewood LC and Taylor WF: Mean amplitude of glycemic
excursions, a measure of diabetic instability. Diabetes.
19:644–655. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ziegler R, Tubili C, Chico A, Guerci B,
Lundberg E, Borchert M, Löffler A, Bloethner S, Weissmann J and
Pfützner A: ProAct study: New features of insulin pumps improve
diabetes management and glycemic control in patients after
transition of continuous subcutaneous insulin infusion systems.
Diabetes Technol Ther. 15:738–743. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu JD, Xu XH, Zhu J, Ding B, Du TX, Gao G,
Mao XM, Ye L, Lee KO and Ma JH: Effect of exenatide on inflammatory
and oxidative stress markers in patients with type 2 diabetes
mellitus. Diabetes Technol Ther. 13:143–148. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Daniele G, Mendoza R Guardado, Winnier D,
Fiorentino TV, Pengou Z, Cornell J, Andreozzi F, Jenkinson C,
Cersosimo E, Federici M, et al: The inflammatory status score
including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and
adiponectin underlies whole-body insulin resistance and
hyperglycemia in type 2 diabetes mellitus. Acta Diabetol.
51:123–131. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ceriello A, Esposito K, Piconi L, Ihnat
MA, Thorpe JE, Testa R, Boemi M and Giugliano D: Oscillating
glucose is more deleterious to endothelial function and oxidative
stress than mean glucose in normal and type 2 diabetic patients.
Diabetes. 57:1349–1354. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gallwitz B: Implications of postprandial
glucose and weight control in people with type 2 diabetes:
Understanding and implementing the international diabetes
federation guidelines. Diabetes Care. 2:(32 Suppl). S322–S513.
2009. View Article : Google Scholar
|
|
23
|
Ceriello A, Quagliaro L, Catone B, Pascon
R, Piazzola M, Bais B, Marra G, Tonutti L, Taboga C and Motz E:
Role of hyperglycemia in nitrotyrosine postprandial generation.
Diabetes Care. 25:1439–1443. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chiasson JL, Josse RG, Leiter LA, Mihic M,
Nathan DM, Palmason C, Cohen RM and Wolever TM: The effect of
acarbose on insulin sensitivity in subjects with impaired glucose
tolerance. Diabetes Care. 19:1190–1203. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hanefeld M, Cagatay M, Petrowitsch T,
Neuser D, Petzinna D and Rupp M: Acarbose reduces the risk for
myocardial infarction in type 2 diabetic patients: Meta-analysis of
seven long-term studies. Eur Heart J. 25:10–16. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ceriello A, Bortolotti N, Falleti E,
Taboga C, Tonutti L, Crescentini A, Motz E, Lizzio S, Russo A and
Bartoli E: Total radical-trapping antioxidant parameter in NIDDM
patients. Diabetes Care. 20:194–197. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
El Midaoui A, Wu R and de Champlain J:
Prevention of hypertension, hyperglycemia and vascular oxidative
stress by aspirin treatment in chronically glucose-fed rats. J
Hypertens. 20:1407–1412. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Esposito K, Nappo F, Marfella R, Giugliano
G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A and Giugliano D:
Inflammatory cytokine concentrations are acutely increased by
hyperglycemia in humans: Role of oxidative stress. Circulation.
106:2067–2072. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tilg H and Moschen AR: Role of adiponectin
and PBEF/visfatin as regulators of inflammation: Involvement in
obesity-associated diseases. Clin Sci (Lond). 114:275–288. 2008.
View Article : Google Scholar : PubMed/NCBI
|
